Why Are Obesity Patients Being Denied Anti-Obesity Medications? It Starts With a Diagnosis Code

Accurate diagnosis and procedure coding has become a critical gatekeeper for identifying patients eligible for advanced obesity treatments, including GLP‑1 therapies. Yet in many organizations, systematic undercoding and overcoding are obscuring the true burden of obesity, leaving high‑risk patients effectively invisible to payers, life sciences companies, and care teams. | Accurate diagnosis and procedure coding has become a critical gatekeeper for identifying patients eligible for advanced obesity treatments, including GLP‑1 therapies.

Raccontata dafiercepharma.com